×
TerrAscend Common Stock Net 2021-2025 | TSNDF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
TerrAscend common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.
View More
TerrAscend Common Stock Net 2021-2025 | TSNDF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
TerrAscend common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$218.9B
Boston Scientific (BSX)
$159.4B
Stryker (SYK)
$153B
EssilorLuxottica (ESLOY)
$136.1B
Medtronic (MDT)
$118B
Lonza Group Ag (LZAGY)
$50.9B
Haleon (HLN)
$43.8B
ResMed (RMD)
$40.1B
GE HealthCare Technologies (GEHC)
$35.4B
Agilent Technologies (A)
$33.9B
Terumo (TRUMY)
$25.3B
Koninklijke Philips (PHG)
$24.9B
Insulet (PODD)
$20.2B
Zimmer Biomet Holdings (ZBH)
$19.3B
Baxter (BAX)
$14.7B
Smith & Nephew SNATS (SNN)
$13.9B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$7B
Lantheus Holdings (LNTH)
$5.1B
Perrigo (PRGO)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.8B
Haemonetics (HAE)
$3.6B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
ICU Medical (ICUI)
$3.2B
LeMaitre Vascular (LMAT)
$1.9B
QuidelOrtho (QDEL)
$1.8B
AtriCure (ATRC)
$1.5B
Acuren (TIC)
$1.4B